News

In this personal essay, hairstylist and curl expert Kys Clark shares how having alopecia has redefined what beauty means to ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.
Sun Pharma has introduced LEQSELVITM (deuruxolitinib) 8 mg tablets in the US for severe alopecia areata after settling a patent dispute with Incyte. Approved by the FDA and backed by strong clinical ...
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Press Trust of India on MSN2d
Sun Pharma shares climb nearly 3 pc
Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for sev ...
A new study published in the Journal of American Medical Association showed that individuals with autoimmune skin diseases ...
LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...
Sun Pharma shares rose nearly 2 per cent on Tuesday after the company launched Leqselvi, a new treatment for severe alopecia ...
Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...